Powered by

Lysophosphatidic Acid Receptor 1 - Pipeline Review, H2 2019 - ResearchAndMarkets.com

Jan 16, 2020 - Business Wire

The "Lysophosphatidic Acid Receptor 1 - Pipeline Review, H2 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Summary

According to the recently published report 'Lysophosphatidic Acid Receptor 1 - Pipeline Review, H2 2019'; Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1) pipeline Target constitutes close to 7 molecules.

Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1) - Lysophosphatidic aci...